A number of health insurance companies throughout
the country are adopting a new specialty tier pricing system for expensive drugs, requiring patients to pay much more for life-saving and disease-stabilizing medications. Insurers are abandoning the traditional arrangement where patients pay a fixed co-pay amount and instead charging patients a percentage of the cost of certain high-priced drugs, usually 25 to 33 percent, which can amount to thousands of dollars a month for vital medications.
The Patients' Access to Treatments Act of 2012 (H.R. 4209) was introduced in March by US House of Representatives David McKinley (R-WV) and Lois Capps (D-CA) to address this important issue. H.R. 4209 requires health insurers to place specialty drugs within the same classification as Tier III non-preferred drugs. It would allow people living with serious devastating health conditions to continue to have access to the critical treatments which they need in order to live active and productive lives.
Click here to find you representative www.house.gov/representatives/find/?utm_so
To read the article and get a template letter, click here fmcpaware.org/specialty-tier-call-to-actio
Central Time Zone
(1 hour slower than EST)
I wish you all JOY and the fulfillment of your dreams.
Baby Step Spark People Team Co Leader
Fighting Fibromyalgia Team Co Leader
Spirited Underdogs Challenge Team
| Pounds lost: 5.0